Magnus Nylén proposed as new member of the SelectImmune Pharma board
Shareholders, who at the time of this press release in total represent more than 50 percent of all votes, have amended their previous proposal to the upcoming Annual General meeting on November 23[rd] concerning the election of chairman of the meeting, board of directors, auditor, and remuneration to the board of directors and auditor (items 2 and 10-15) to the following proposal. Jan Zetterberg, who is the company's lawyer, is proposed as chairman of the meeting. Furthermore, five board members are proposed without a deputy. Fee for the chairman of the board is not paid, a fixed fee of